Aurobindo Pharma
On verge of a breakout from a triangle.
Sun Pharma – Breakout with good volumes above 600. A 1 year consolidation.
Strides Shasun – A major fall but some indications of a turnaround on sustaining 420-430.
Disclosure – The stocks have been recommended in our advisory services.
1) Technical Analysis Training – Mumbai – 18th-19th August 2018
Trainer – Nooresh Merani & N S Fidai
Payment Link , Course Content & Venue Details - https://www.instamojo.com/analyseindia/technical-analysis-training-mumbai-18th-19th/
2) Technical Analysis Training Bangalore – 25th-26th August 2018
Trainer – N S Fidai
Payment Link , Course Content & Venue Details - https://www.instamojo.com/analyseindia/technical-analysis-training-bangalore25th-an/
3 ) Technical Analysis Training Delhi – 08th-09th September 2018 -
Trainer – N S Fidai
https://www.instamojo.com/analyseindia/technical-analysis-training-delhi-8th-9th-se/
For our services check link on top of website –
Can subscribe to The Agnostic Portfolio ( Its down 10-12 % since launch in mid April) .
For Derivatives - https://nooreshtech.co.in/quickgains
QuickGains F&O
The product is for traders with a High RIsk Profile and High Risk Apetite. Holding period of positions is 1-15 sessions generally.
DISCLOSURE Nooresh Merani
Securities covered above: All mentioned in the above post
SEBI Registration disclosure - Investment Adviser ( INA000002991)
Financial Interest:
Nooresh Merani and his family/associates/ analysts would not have exposure in the securities mentioned in the above report/article.
Nooresh Merani and his family/associates/ analysts do not have any financial interest/beneficial ownership of more than 1% in the company covered by Analyst.
Nooresh Merani and his family/associates/ analysts have not received any compensation from the company/third party covered in the above report/article ever.
Nooresh Merani and his family/associates/ analysts has not served as an officer, director or employee of company covered in the report/article and has not been engaged in market-making activity of the company covered in the report/article.
The views expressed are based solely on information available publicly and believed to be true. Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision
Also read the detailed disclaimer - https://nooreshtech.co.in/disclaimer
